Abstract Submission Deadline: Sunday, 14 April 2024 Abstract submissions for presentation at AADPA's 7th Annual Conference are now invited. AADPA’s 7th Annual Conference will be held in Brisbane from 27…
Kim FullerDecember 7, 2023
Updated: November 2023 All states and territories within Australia and New Zealand have their own laws about Schedule 8 (ie dangerous drugs/poisons) which includes stimulants. Currently, all states and territories…
Kim FullerNovember 11, 2023
The Australian ADHD Professionals Association welcomes and supports the 15 key recommendations contained in the Senate Report released on Monday.
Kim FullerNovember 7, 2023
The Australian Evidence-Based Clinical Guideline For ADHD is a clinical practice guideline for the identification, diagnosis, and treatment of people with ADHD.
Kim FullerNovember 6, 2023
Read AADPA's Senate Inquiry submission based on evidence from the ADHD Clinical Practice Guideline which includes a call to develop a National ADHD Strategy.
Kim FullerOctober 1, 2023
Join Senator Marielle Smith, Deputy Chair of the Senate ADHD Inquiry for a special Q&A session with Prof. Mark Bellgrove.
Kim FullerOctober 1, 2023
Prof. Edward Ogden presents how and when to initiate treatment for ADHD in people with a history of drug & alcohol misuse.
Kim FullerAugust 31, 2023
This webinar discusses the challenges faced by GPs as the number of patients seeking ADHD assessment, diagnosis and intervention continues to rise.
Kim FullerAugust 15, 2023
AADPA’s 6th Annual Conference was held in Melbourne from 29 - 30 July 2023, with additional workshops on Friday, 28 July. The conference was held in a hybrid fashion with…
Kim FullerJuly 5, 2023
